Atrium Therapeutics, Inc. stock forecast
Want to see RNA full AI Analyst Report?
Atrium Therapeutics, Inc. (RNA) Stock Forecast & Price Target
RNA Analyst Ratings
RNA Stock 12 Month Forecast
Average Price Target
$21.25▲(182.96% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Yanan Zhu | Wells Fargo | $25 | buy | 232.89%Upside | Assigned | 11/16/26 | ||
| Boobalan Pachaiyappan | Roth MKM | $15 | buy | 99.73%Upside | Reiterated | 11/13/26 | ||
| Mitchell Kapoor | H.C. Wainwright | $20 | buy | 166.31%Upside | Reiterated | 11/13/26 | ||
| Kristen Kluska | Cantor Fitzgerald | $25 | buy | 232.89%Upside | Reiterated | 10/14/26 | ||
| Joseph Schwartz | Leerink Partners | $25 | buy | 232.89%Upside | Initiated | 05/15/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Yanan ZhuWells Fargo | BuyAssigned$25 | 11/16/26 | 232.89%Upside | ||
| Boobalan PachaiyappanRoth MKM | BuyReiterated$15 | 11/13/26 | 99.73%Upside | ||
| Mitchell KapoorH.C. Wainwright | BuyReiterated$20 | 11/13/26 | 166.31%Upside | ||
| Kristen KluskaCantor Fitzgerald | BuyReiterated$25 | 10/14/26 | 232.89%Upside | ||
| Joseph SchwartzLeerink Partners | BuyInitiated$25 | 05/15/26 | 232.89%Upside |
Best Analysts Covering Atrium Therapeutics, Inc.
Copying Mitchell Kapoor's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -13.87% per trade.
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.13% per trade.
Copying Mitchell Kapoor's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -16.13% per trade.
RNA Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 6 | 5 | 8 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 6 | 5 | 8 | 7 |
In the current month, RNA has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RNA average Analyst price target in the past 3 months is 21.25.

